TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2292630

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral alcohol skills training
Number of subjects: 36

Group type: COMPARATOR
Intervention: Didactic alcohol information program
Number of subjects: 36

Group type: COMPARATOR
Intervention: Assessment only
Number of subjects: 36
Study: 7030714

Group type: EXPERIMENTAL
Intervention: 5-nitrox (200 to 250 mg, mean 3 mg/kg of body weight)
Number of subjects: 8

Group type: COMPARATOR
Intervention: 5-nok (administered under the same conditions)
Number of subjects: 8
Study: 31420374

Group type: EXPERIMENTAL
Intervention: High-emotion-arousing PWLs
Number of subjects: 1503

Group type: EXPERIMENTAL
Intervention: Low-emotion-arousing PWLs
Number of subjects: 1503

Group type: EXPERIMENTAL
Intervention: Negative emotions
Number of subjects: 1503

Group type: COMPARATOR
Intervention: PWLs
Number of subjects: 1503
Study: 30743037

Group type: EXPERIMENTAL
Intervention: 3D printed models (3DPMs)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 3D images (3DIs)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 2D images (2DIs)
Number of subjects: 60
Study: 27967333

Group type: EXPERIMENTAL
Intervention: Cemented total hip replacement (THR)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Uncemented total hip replacement (THR)
Number of subjects: 69
Study: 26358535

Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 436

Group type: COMPARATOR
Intervention: Cancer screening comparison condition
Number of subjects: 436
Study: 23418103

Group type: EXPERIMENTAL
Intervention: Weight loss intervention over 12 months
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Genetic predisposition scores (GPS) for total cholesterol (TC)
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Genetic predisposition scores (GPS) for low density lipoprotein cholesterol (LDLC)
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Genetic predisposition scores (GPS) for high density lipoprotein cholesterol (HDLC)
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Genetic predisposition scores (GPS) for triglycerides (TG)
Number of subjects: 374
Study: 21690460

Group type: EXPERIMENTAL
Intervention: onabotulinumtoxinA (10 U)
Number of subjects: 90

Group type: COMPARATOR
Intervention: abobotulinumtoxinA (30 U)
Number of subjects: 90
Study: 19909548

Group type: EXPERIMENTAL
Intervention: Certolizumab pegol (CZP) plus methotrexate (MTX)
Number of subjects: 982

Group type: COMPARATOR
Intervention: Placebo (PBO) plus methotrexate (MTX)
Number of subjects: 982
Study: 17910331

Group type: EXPERIMENTAL
Intervention: Azelastine nasal spray, 1 spray per nostril twice daily
Number of subjects: 554

Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 554
Study: 15475903

Group type: EXPERIMENTAL
Intervention: Non-steroidal anti-inflammatory drugs (NSAIDs)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cyclo-oxygenase-2 (COX-2) inhibitors
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Paracetamol 600/650 mg plus codeine 60 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 11796077

Group type: EXPERIMENTAL
Intervention: Relaxing music (Pachelbel's Canon in D major)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Silence (Control)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Relaxing music
Number of subjects: 87
Study: 9760898

Group type: EXPERIMENTAL
Intervention: TiO‐blasted implants
Number of subjects: 50

Group type: COMPARATOR
Intervention: Machined implants
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both types of implants
Number of subjects: 50
Study: 7802196

Group type: EXPERIMENTAL
Intervention: Plasma‐Lyte 148 (magnesium‐containing crystalloid solution)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Compound sodium lactate solution (maintenance crystalloid)
Number of subjects: 30
Study: 2973169

Group type: EXPERIMENTAL
Intervention: Orchiectomy plus antiandrogen Flutamide
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Depot LH‐RH analog Zoladex plus Flutamide
Number of subjects: 99

Group type: COMPARATOR
Intervention: Orchiectomy alone
Number of subjects: 99

Group type: COMPARATOR
Intervention: Zoladex alone
Number of subjects: 99
Study: 31218842

Group type: EXPERIMENTAL
Intervention: Neoadjuvant dual anti-HER2 therapy and taxane
Number of subjects: 19
Study: 30021551

Group type: EXPERIMENTAL
Intervention: Stress Management (SM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stress Management with Buddy (SM-B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control Condition (CC)
Number of subjects: 0
Study: 27793446

Group type: EXPERIMENTAL
Intervention: Stereotactic radiotherapy of the tumor bed (SRT-TB)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Whole-brain radiotherapy (WBRT)
Number of subjects: 59
Study: 23124538

Group type: EXPERIMENTAL
Intervention: Guided imagery
Number of subjects: 72

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 72
Study: 22592572

Group type: EXPERIMENTAL
Intervention: 1000 mg vitamin C daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 19860602

Group type: EXPERIMENTAL
Intervention: Outpatient-based exercise programme at 8 weeks post-surgery
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Performance in 6MWT at 8 weeks
Number of subjects: 100
Study: 18689550

Group type: EXPERIMENTAL
Intervention: Combination of diet and exercise (DE)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Diet alone (D)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Exercise alone (E)
Number of subjects: 90
Study: 15311026

Group type: EXPERIMENTAL
Intervention: HoLEP
Number of subjects: 200

Group type: COMPARATOR
Intervention: TURP
Number of subjects: 200
Study: 11433088

Group type: COMPARATOR
Intervention: CT (Conventional Treatment)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: CTM (Conventional Treatment with 2 Anorectal Manometry sessions)
Number of subjects: 212
Study: 9609557

Group type: EXPERIMENTAL
Intervention: Antibiotic therapy with glucocorticoids
Number of subjects: 509

Group type: COMPARATOR
Intervention: Antibiotic therapy without glucocorticoids
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Logistic regression analysis
Number of subjects: 509
Study: 8054247

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) 250 mg orally
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Dideoxyinosine (ddI) 250 mg orally
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Combination of ZDV 250 mg plus ddI 250 mg orally
Number of subjects: 8
Study: 2455426

Group type: EXPERIMENTAL
Intervention: Topical minoxidil lotion (2% and 5%)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo minoxidil lotion
Number of subjects: 9
Study: 29734977

Group type: EXPERIMENTAL
Intervention: Group 1: positive airway pressure flow (PAP flow), chest and abdominal effort, and snoring
Number of subjects: 65

Group type: COMPARATOR
Intervention: Group 2: smoothed PAP flow and effort (CW‐EMG‐EF)
Number of subjects: 65
Study: 28772041

Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM) therapy
Number of subjects: 1000
Study: 26280577

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (LDA)
Number of subjects: 1078
Study: 24477734

Group type: EXPERIMENTAL
Intervention: Aerobic walking exercise
Number of subjects: 22

Group type: COMPARATOR
Intervention: Stretching exercise
Number of subjects: 22
Study: 20658529

Group type: EXPERIMENTAL
Intervention: Imiquimod treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Frequent NSAID-use
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NSAID-use
Number of subjects: 0
Study: 18345708

Group type: EXPERIMENTAL
Intervention: Bevacizumab plus interferon-alpha-2a
Number of subjects: 1381

Group type: COMPARATOR
Intervention: Placebo plus interferon-alpha-2a
Number of subjects: 1381
Study: 16447103

Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 604

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 604
Study: 14633566

Group type: EXPERIMENTAL
Intervention: Combined general and epidural anesthesia
Number of subjects: 30

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 30
Study: 10847236

Group type: EXPERIMENTAL
Intervention: Elevated homocysteine
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: MTHFR mutation (677 C‐‐>T)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Decreased activated protein C resistance ratio
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Decreased protein C levels
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Combination of two risk factors
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Combination of three risk factors
Number of subjects: 101
Study: 9342007

Group type: EXPERIMENTAL
Intervention: Second-generation assay for cardiac troponin T (cTnT) on the Enzymun system
Number of subjects: 0

Group type: COMPARATOR
Intervention: First-generation assay for cardiac troponin T (cTnT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Second-generation assay for cardiac troponin T (cTnT)
Number of subjects: 0
Study: 8170796

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation training
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 15
Study: 3535017

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Colloidal bismuth subcitrate (CBS)
Number of subjects: 0
Study: 31038012

Group type: EXPERIMENTAL
Intervention: RESCUE intervention (problem-solving and skills-building intervention for stroke caregivers)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 29477094

Group type: EXPERIMENTAL
Intervention: Comparison of familiar category instances with highlighted function information
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attention to function information
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Comparison of two perceptually similar category members
Number of subjects: 0
Study: 27809848

Group type: EXPERIMENTAL
Intervention: Sitagliptin treatment
Number of subjects: 463

Group type: COMPARATOR
Intervention: Conventional anti-diabetic agents
Number of subjects: 463

Group type: EXPERIMENTAL
Intervention: Good glycemic control (HbA1c <7.0)
Number of subjects: 463

Group type: EXPERIMENTAL
Intervention: Poor glycemic control (HbA1c ≥7.0)
Number of subjects: 463
Study: 24508847

Group type: COMPARATOR
Intervention: Cardiac MR
Number of subjects: 898

Group type: COMPARATOR
Intervention: SPECT-MIBI
Number of subjects: 898

Group type: COMPARATOR
Intervention: ECHO
Number of subjects: 898
Study: 22082673

Group type: EXPERIMENTAL
Intervention: Catheter ablation (CA)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Surgical ablation (SA)
Number of subjects: 124
Study: 20557816

Group type: EXPERIMENTAL
Intervention: PLDLA metatarsophalangeal joint interposition arthroplasty
Number of subjects: 35

Group type: COMPARATOR
Intervention: Conventional metatarsal head resection
Number of subjects: 35
Study: 18726111

Group type: EXPERIMENTAL
Intervention: Individual leg plantar flexion training (4 x 4 min intervals at 80% of maximal work rate, three times per week for 8 weeks)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Individual leg plantar flexion training
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 27
Study: 15190858

Group type: EXPERIMENTAL
Intervention: Quality improvement intervention based on a model of practice change.
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Understanding the four key elements of practice change.
Number of subjects: 79
Study: 11106050

Group type: EXPERIMENTAL
Intervention: Early Discharge
Number of subjects: 308

Group type: COMPARATOR
Intervention: Routine Discharge
Number of subjects: 308
Study: 9217377

Group type: EXPERIMENTAL
Intervention: 1500000 KIU of aprotinin (group A)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 300000 KIU of aprotinin (group B)
Number of subjects: 200

Group type: COMPARATOR
Intervention: No aprotinin (group C)
Number of subjects: 200
Study: 8376274

Group type: EXPERIMENTAL
Intervention: Indomethacin (100 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 10276475

Group type: EXPERIMENTAL
Intervention: Health education program
Number of subjects: 310
Study: 31159796

Group type: EXPERIMENTAL
Intervention: Well-being therapy (WBT) for 5 weeks, n=39
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo control condition (CC) for 5 weeks, n=48
Number of subjects: 101
Study: 29247098

Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention inspired by Stuifbergen's model; conducted during three nurse-led sessions.
Number of subjects: 71
Study: 25881796

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (single dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study: 24680087

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TA) - intravenous 1 g bolus, 1 g infusion/8 h
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 22001815

Group type: EXPERIMENTAL
Intervention: 0.25% fluorescein with 0.5% proxymetacaine hydrochloride dye
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Rinsing with 2 ml of balanced saline solution
Number of subjects: 15
Study: 19155004

Group type: EXPERIMENTAL
Intervention: Metformin plus cyclic medroxyprogesterone acetate (MPA) 5 mg twice a day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Metformin 850 mg twice a day
Number of subjects: 40
Study: 17519068

Group type: EXPERIMENTAL
Intervention: bimatoprost/timolol fixed combination (BTFC)
Number of subjects: 36

Group type: COMPARATOR
Intervention: latanoprost/timolol fixed combination (LTFC)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 36
Study: 15551160

Group type: EXPERIMENTAL
Intervention: co‐trimoxazole plus doxycycline (CD group)
Number of subjects: 280

Group type: COMPARATOR
Intervention: co‐trimoxazole plus rifampin (CR group)
Number of subjects: 280
Study: 11032226

Group type: EXPERIMENTAL
Intervention: Closed kinetic chain exercises
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open kinetic chain exercises
Number of subjects: 60
Study: 9094726

Group type: EXPERIMENTAL
Intervention: 3 doses of nebulized ipratropium added to three albuterol nebulizations administered over 1 hour
Number of subjects: 120

Group type: COMPARATOR
Intervention: 0 doses of nebulized ipratropium added to three albuterol nebulizations administered over 1 hour
Number of subjects: 120
Study: 7682029

Group type: EXPERIMENTAL
Intervention: Risperidone 4-12 mg
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 2823869

Group type: EXPERIMENTAL
Intervention: Dietary fibre isolates (various water-soluble chemical isolates)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control meal
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Dietary fibre isolates
Number of subjects: 6
Study: 30425014

Group type: EXPERIMENTAL
Intervention: Buzzy (thermomechanical stimulation) during injection
Number of subjects: 497

Group type: COMPARATOR
Intervention: Control group (no Buzzy)
Number of subjects: 497
Study: 29797235

Group type: EXPERIMENTAL
Intervention: Roflumilast 250 μg once daily for 4 weeks
Number of subjects: 1238

Group type: COMPARATOR
Intervention: Roflumilast 500 μg every other day
Number of subjects: 1238

Group type: COMPARATOR
Intervention: Roflumilast 500 μg once daily
Number of subjects: 1238
Study: 27634091

Group type: EXPERIMENTAL
Intervention: Connective tissue manipulation (CTM) twice per week for 6 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional treatment (CG)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Connective tissue manipulation (CTM)
Number of subjects: 20
Study: 25714532

Group type: EXPERIMENTAL
Intervention: Mini-flared 45-degree Kelman tip
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Reversed mini-flared 30-degree Kelman tip
Number of subjects: 150

Group type: COMPARATOR
Intervention: Sidewinder 30-degree Kelman tip
Number of subjects: 150
Study: 23875818

Group type: EXPERIMENTAL
Intervention: Prophylactic single-dose antibiotic administered preoperatively
Number of subjects: 953

Group type: COMPARATOR
Intervention: Prophylactic single-dose antibiotic administered at cord clamping
Number of subjects: 953
Study: 20921085

Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg/day) 3 weeks before surgery
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (10 mg/kg, single shot)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study: 18263802

Group type: EXPERIMENTAL
Intervention: Dichloroacetate (DCA) infusion (50 mg/kg body mass)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 18
Study: 16698215

Group type: EXPERIMENTAL
Intervention: Fluconazole
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Candiduria
Number of subjects: 182
Study: 14620117

Group type: EXPERIMENTAL
Intervention: MTX microtextured implant surfaces
Number of subjects: 9

Group type: COMPARATOR
Intervention: Machined implant surfaces
Number of subjects: 9
Study: 10928438

Group type: COMPARATOR
Intervention: Bupivacaine 0.25% caudally (0.5 mL kg(‐1))
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% caudally (0.5 mL kg(‐1)) + Clonidine (1 microg kg(‐1))
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% caudally (0.5 mL kg(‐1)) + Sufentanil (0.5 microg kg(‐1))
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% caudally (0.5 mL kg(‐1)) + Clonidine (0.5 microg kg(‐1)) + Sufentanil (0.25 microg kg(‐1))
Number of subjects: 60
Study: 8909667

Group type: EXPERIMENTAL
Intervention: Inhaled aerosolized prostacyclin 50 ng/kg/min
Number of subjects: 5

Group type: COMPARATOR
Intervention: Nitric oxide 10 ppm
Number of subjects: 5
Study: 1565753

Group type: EXPERIMENTAL
Intervention: Women aware of the menstrual cycle focus of the study (asymptomatic group)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Women with severe symptoms (LLPDD group)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Women unaware of the menstrual cycle focus of the study (asymptomatic group)
Number of subjects: 65
Study: 31907755

Group type: EXPERIMENTAL
Intervention: Bystander intervention (Green Dot presentations and intensive bystander training)
Number of subjects: 74836

Group type: EXPERIMENTAL
Intervention: Bystander intervention
Number of subjects: 74836

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 74836
Study: 30473179

Group type: EXPERIMENTAL
Intervention: Baseline CRP levels (very high)
Number of subjects: 867

Group type: EXPERIMENTAL
Intervention: Normal CRP at weeks 2, 4, and 8
Number of subjects: 867

Group type: EXPERIMENTAL
Intervention: Baseline CRP levels
Number of subjects: 867

Group type: EXPERIMENTAL
Intervention: Baseline and post-baseline CRP levels
Number of subjects: 867
Study: 28841847

Group type: EXPERIMENTAL
Intervention: Patients who are activated (e.g., ask questions, express opinions, ask for clarification)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Patients who are typical (not activated)
Number of subjects: 91
Study: 25134036

Group type: EXPERIMENTAL
Intervention: Personalized normative feedback (PNF) intervention
Number of subjects: 480
Study: 24460069

Group type: EXPERIMENTAL
Intervention: Daily walking intervention (10,000 steps per day and a weekly supervised group walk) for 10 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daily walking intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 21842965

Group type: EXPERIMENTAL
Intervention: Probability discounting
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Delay discounting
Number of subjects: 226
Study: 19709327

Group type: EXPERIMENTAL
Intervention: Aqueous leaf extracts of Syzygium cumini (ASC) at 60-1000 microg/mL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aqueous leaf extracts of Syzygium cumini (ASC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hyperglycemic serum
Number of subjects: 0
Study: 17490981

Group type: EXPERIMENTAL
Intervention: Rye-pasta diet
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Oat-wheat-potato diet
Number of subjects: 47
Study: 15760312

Group type: EXPERIMENTAL
Intervention: Surgical management
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Medical management (vaginal misoprostol)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Expectant management
Number of subjects: 40

Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 40
Study: 12377799

Group type: EXPERIMENTAL
Intervention: 2.5 micro g LT
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 0.5 micro g LT
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 0.1 micro g LT
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: no LT
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Enterically delivered urease
Number of subjects: 42
Study: 10199429

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens, 1.25 mg/d for 21 days
Number of subjects: 46
Study: 7754476

Group type: EXPERIMENTAL
Intervention: Homeopathic treatments (various drugs prescribed by homeopathic physicians)
Number of subjects: 237
Study: 2271192

Group type: EXPERIMENTAL
Intervention: 3-hour nil per os (NPO) group (19 infants kept NPO for 3 hours following ingestion of up to 4 ounces of 5% dextrose in water)
Number of subjects: 44

Group type: COMPARATOR
Intervention: 10-hour NPO group (25 infants who remained NPO an average of 10 hours prior to surgery)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Dye-dilution technique
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Aspiration technique
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 44
Study: 7361691

Group type: EXPERIMENTAL
Intervention: Wholemeal bread
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: White bread enriched with zinc chloride
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wholemeal bread with added calcium (milk products)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meals containing milk, cheese, beef, and egg with wholemeal bread
Number of subjects: 0
Study: 31805422

Group type: COMPARATOR
Intervention: Stepped-wedge cluster randomized controlled trial design
Number of subjects: 0

Group type: COMPARATOR
Intervention: Typical SW design
Number of subjects: 0

Group type: COMPARATOR
Intervention: SW design with multiple clusters crossing over per period
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hierarchical randomization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nested substudies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hybrid SW design
Number of subjects: 0

Group type: COMPARATOR
Intervention: Incomplete SW design variations
Number of subjects: 0